Olson, Mary K. - In: Journal of Health Economics 27 (2008) 2, pp. 175-200
Drug review speed has increased substantially in the 1990s, largely due to industry-funded user fees. Following several drug withdrawals, however, new questions have emerged about the effects of this change on drug safety. This article examines the impact of review speed and user fees on counts...